These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 303211)

  • 41. [Improvement in the specificity of the PABA test (PFT) by combined PABA peptide/D-xylose administration and serum kinetic measurement?].
    Bornschein W
    Z Gastroenterol; 1985 May; 23(5):247-56. PubMed ID: 3878635
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new method of testing pancreatin therapy in vivo by the use of a peroral chymotrypsin substrate 4-(N-acetyl-L-tyrosyl)aminobenzoic acid.
    Fric P; Malis F; Kasafírek E; Slabý J
    Hepatogastroenterology; 1980 Jun; 27(3):220-3. PubMed ID: 6970159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Specificity and sensitivity of the 4-N-acetyl-L-tyrosyl-p- aminobenzoic acid test in childhood with serum p-aminobenzoic acid determination].
    Henker J; Sprössig C
    Dtsch Z Verdau Stoffwechselkr; 1988; 48(2):80-2. PubMed ID: 3262502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The PABA test for evaluation of exocrine pancreatic function: a review of the literature.
    Hoek FJ
    Neth J Med; 1988 Apr; 32(3-4):143-56. PubMed ID: 3283581
    [No Abstract]   [Full Text] [Related]  

  • 45. [The PABA test in chronic pancreatitis: value of plasma para-amino benzoic acid determinations (author's transl)].
    Breau JP; Théodore C; Evstigneeff T; Sancho J; Vitaux J; Delacoux E; Paolaggi JA
    Nouv Presse Med; 1981 Dec; 10(44):3631-3. PubMed ID: 6976562
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical studies on the exocrine pancreatic function test by oral administration of N-benzoyl-L-tyrosyl-PABA combined with the PABA absorption test (author's transl)].
    Kimura T; Wakasugi H; Funakoshi A; Matsumoto M; Ibayashi H
    Nihon Shokakibyo Gakkai Zasshi; 1979 Feb; 76(2):259-65. PubMed ID: 312346
    [No Abstract]   [Full Text] [Related]  

  • 47. [Testing exocrine pancreas function using the PABA peptide test in childhood].
    Osswald P
    Monatsschr Kinderheilkd (1902); 1980 May; 128(5):340-2. PubMed ID: 6968400
    [No Abstract]   [Full Text] [Related]  

  • 48. [Exocrine pancreatic insufficiency. Chymotrypsin determination and peptide PABA test].
    Thienhaus R; Niederau C; Tennie U
    Dtsch Med Wochenschr; 1978 Sep; 103(35):1358-60. PubMed ID: 308002
    [No Abstract]   [Full Text] [Related]  

  • 49. [Testing of the exocrine pancreatic function using N-benzoyl-L-tyrosyl-PABA].
    Stalder GA; Kayasseh L; Gyr K
    Dtsch Med Wochenschr; 1976 Sep; 101(39):1428-30. PubMed ID: 976113
    [No Abstract]   [Full Text] [Related]  

  • 50. [The specificity of peptide-PABA-test (author's transl)].
    Freise J; Hofmann R
    Z Gastroenterol; 1979 May; 17(5):310-7. PubMed ID: 313633
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PABA screening test for exocrine pancreatic function in infants and children.
    Sacher M; Kobsa A; Shmerling DH
    Arch Dis Child; 1978 Aug; 53(8):639-41. PubMed ID: 309317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Practical assessment of the NBT-PABA pancreatic function test using high performance liquid chromatography determination of p-aminobenzoic acid in urine.
    Berg JD; Chesner I; Lawson N
    Ann Clin Biochem; 1985 Nov; 22 ( Pt 6)():586-90. PubMed ID: 3878124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved sensitivity of the BTPABA pancreatic function test in animals with meals of raw egg white.
    Imondi AR; Wolgemuth RL
    Dig Dis Sci; 1979 Mar; 24(3):214-6. PubMed ID: 313325
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic tests of exocrine pancreatic function and disease.
    Arvanitakis C; Cooke AR
    Gastroenterology; 1978 May; 74(5 Pt 1):932-48. PubMed ID: 76589
    [No Abstract]   [Full Text] [Related]  

  • 55. A simple assay for measurement of urinary p-aminobenzoic acid in the oral pancreatic function test.
    Yamato C; Kinoshita K
    Anal Biochem; 1979 Sep; 98(1):13-7. PubMed ID: 317421
    [No Abstract]   [Full Text] [Related]  

  • 56. Diagnosis of pancreatic disease by a synthetic peptide. A new test of exocrine pancreatic function.
    Arvanitakis C; Greenberger NJ
    Lancet; 1976 Mar; 1(7961):663-6. PubMed ID: 73639
    [No Abstract]   [Full Text] [Related]  

  • 57. Oral administration of a chymotrypsin-labile peptide--a new test of exocrine pancreatic function in man (PFT).
    Gyr K; Stalder GA; Schiffmann I; Fehr C; Vonderschmitt D; Fahrlaender H
    Gut; 1976 Jan; 17(1):27-32. PubMed ID: 1269977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pancreatic exocrine function in biliary tract diseases: stability test and clinical evaluation.
    Ker CG; Hou MF; Lee KT; Huang TJ; Sheen PC; Peng CF
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1985 Sep; 1(9):532-7. PubMed ID: 3879965
    [No Abstract]   [Full Text] [Related]  

  • 59. Synthetic peptides in the diagnosis of exocrine pancreatic insufficiency in animals.
    Imondi AR; Stradley RP; Wolgemuth R
    Gut; 1972 Sep; 13(9):726-31. PubMed ID: 4639406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of methods of correction for interference in the PABA test for exocrine pancreatic function.
    Ward CD; Linton AS; Rowe DJ
    Clin Chem; 1986 Jul; 32(7):1430-1. PubMed ID: 3487394
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.